Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2008 Apr 10;39:291–320. doi: 10.1016/S0065-3527(08)60798-8

Pathogenesis of Theiler's Murine Encephalomyelitis Virus

Masahito Yamada 1, Andreas Zurbriggen 1, Robert S Fujinami 1,*
PMCID: PMC7130615  PMID: 2038955

Publisher Summary

Theiler's murine encephalomyelitis virus belongs to the family of picornaviridae. Picornaviruses are small ( “pico”), phylogenetically related RNA viruses. Based on different biochemical and biophysical characteristics picornaviruses are subdivided into four groups: enteroaphthovirus (foot-and-mouth disease virus), cardiovirus [encephalomyocarditis virus (EMCV), Mengo virus], and rhinovirus (human rhinovirus). Theiler's murine encephalomyelitis virus was originally classified among the picornaviridae as an enterovirus because of its biological similarities with poliovirus. Further comparison of the complete genome of TMEV BeAn 8386 strain identifies remarkable similarities at the level of nucleotides and predicted amino acids between BeAn and the cardioviruses EMCV and Mengo virus. Theiler's murine encephalomyelitis virus is a single-stranded nonenveloped RNA virus. The viral RNA is of positive sense, having the same polarity as mRNA. Viral mRNA lacks the cap structure found at the 5’ end of almost all eukaryotic mRNAs.

References

  1. Acharaya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature (London) 1989;337:709–716. doi: 10.1038/337709a0. [DOI] [PubMed] [Google Scholar]
  2. Aubert C., Chamorro M., Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 1987;3:319–326. doi: 10.1016/0882-4010(87)90002-7. [DOI] [PubMed] [Google Scholar]
  3. Barbano R.L., Dal Canto M.C. Serum and cells from Theiler's virus-infected mice fail to injure myelinating cultures or to produce in vivo transfer of disease. The pathogenesis of Theiler's virus-induced demyelination appears to differ from that of EAE. J. Neurol. Sci. 1984;66:283–293. doi: 10.1016/0022-510x(84)90017-0. [DOI] [PubMed] [Google Scholar]
  4. Blakemore W.F., Welsh C.J.R., Tonks P., Nash A.A. Observations on demyelinating lesions induced by Theiler's virus in CBA mice. Acta Neuropathol. 1988;76:581–589. doi: 10.1007/BF00689596. [DOI] [PubMed] [Google Scholar]
  5. Brahic M., Stroop W.G., Baringer J.R. Theiler's virus persists in glial cells during demyelinating disease. Cell. 1981;26:123–128. doi: 10.1016/0092-8674(81)90040-4. [DOI] [PubMed] [Google Scholar]
  6. Brahic M., Haase A.T., Cash E. Simultaneous in situ detection of viral RNA and antigens. Proc. Natl. Acad. Sci. U.S.A. 1984;81:5445–5448. doi: 10.1073/pnas.81.17.5445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Burns C.C., Lawson M.A., Semler B.L., Ehrenfeld E. Effects of mutations in poliovirus 3Dpol on RNA polymerase activity and on polyprotein cleavage. J. Virol. 1989;63:4866–4874. doi: 10.1128/jvi.63.11.4866-4874.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calenoff M.A., Faaberg K.S., Lipton H.L. Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc. Natl. Acad. Sci. U.S.A. 1990;87:978–982. doi: 10.1073/pnas.87.3.978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carrol A.R., Rowlands D.J., Clarke B.E. The complete nucleotide sequence of the RNA coding for the primary translation product of foot-and-mouth disease virus. Nucleic Acids Res. 1984;12:2461–2472. doi: 10.1093/nar/12.5.2461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cash E., Bandeira A., Chirinian S., Brahic M. Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J. Immunol. 1989;143:984–988. [PubMed] [Google Scholar]
  11. Chamorro M., Aubert C., Brahic M. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. J. Virol. 1986;57:992–997. doi: 10.1128/jvi.57.3.992-997.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clatch R.J., Melvold R.W., Miller S.D., Lipton H.L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region, correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 1985;135:1408–1414. [PubMed] [Google Scholar]
  13. Clatch R.J., Lipton H.L., Miller S.D. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity response in TMEV-induced demyelinating disease, correlation with clinical signs. J. Immunol. 1986;136:920–927. [PubMed] [Google Scholar]
  14. Clatch R.J., Melvold R.W., Dal Canto M.C., Miller S.D., Lipton H.L. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalent of HLA-A, B, and C. J. Neuroimmunol. 1987;15:121–135. doi: 10.1016/0165-5728(87)90087-7. [DOI] [PubMed] [Google Scholar]
  15. Clatch R.J., Lipton H.L., Miller S.D. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. II. Survey of host immune responses and central nervous system virus titers in inbred mouse strains. Microb. Pathog. 1987;3:327–337. doi: 10.1016/0882-4010(87)90003-9. [DOI] [PubMed] [Google Scholar]
  16. Clatch R.J., Pevear D.C., Rozhon E., Roos R.P., Miller S.D., Lipton H.L. Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins. J. Gen. Virol. 1987;68:3191–3196. doi: 10.1099/0022-1317-68-12-3191. [DOI] [PubMed] [Google Scholar]
  17. Cohen J.I., Ticehurst J.R., Feinstone S.M. Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J. Virol. 1987;61:3035–3039. doi: 10.1128/jvi.61.10.3035-3039.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dal Canto M.C. Uncoupled relationship between demyelination and primary infection of myelinating cells in Theiler's virus encephalomyelitis. Infect. Immun. 1982;35:1133–1138. doi: 10.1128/iai.35.3.1133-1138.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dal Canto M.C., Barbano R.L. Remyelination during remission in Theiler's virus infection. Am. J. Pathol. 1984;116:30–45. [PMC free article] [PubMed] [Google Scholar]
  20. Dal Canto M.C., Lipton H.L. Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab. Invest. 1975;33:626–637. [PubMed] [Google Scholar]
  21. Dal Canto M., Lipton H.L. Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J. Neurol. Sci. 1979;42:391–405. doi: 10.1016/0022-510x(79)90172-2. [DOI] [PubMed] [Google Scholar]
  22. Dal Canto M.C., Lipton H.L. Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus. Am. J. Pathol. 1980;98:101–122. [PMC free article] [PubMed] [Google Scholar]
  23. Dal Canto M.C., Lipton H.L. Ultrastructual immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 1982;106:20–29. [PMC free article] [PubMed] [Google Scholar]
  24. Dalziel R.G., Lampert P.W., Talbot P.J., Buchmeier M.J. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 1986;59:463–471. doi: 10.1128/jvi.59.2.463-471.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Daniels J.B., Pappenheimer A.M., Richardson S. Observations on encephalomyelitis of mice (DA strain) J. Exp. Med. 1952;96:517–530. doi: 10.1084/jem.96.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dean D.J. Mouse encephalomyelitis. Immunologic studies of a non-infected colony. J. Immunol. 1951;66:347–359. [PubMed] [Google Scholar]
  27. Fleming J.O., Trousdale M.D., El-Zaatari F.A.K., Stohlman S.A., Weiner L.P. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 1986;58:869–875. doi: 10.1128/jvi.58.3.869-875.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Frankel G., Friedmann A., Amir A., David Y., Shahar A. Theiler's virus replication in isolated Schwann cell culture. J. Neurosci. Res. 1986;15:127–136. doi: 10.1002/jnr.490150202. [DOI] [PubMed] [Google Scholar]
  29. Friedmann A., Frankel G., Lorch Y., Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice, critical importance of timing of treatment. J. Virol. 1987;61:898–903. doi: 10.1128/jvi.61.3.898-903.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Fujinami R.S., Zurbriggen A. Is Theiler's murine encephalomyelitis virus infection of mice an autoimmune disease? APMIS. 1989;97:1–8. doi: 10.1111/j.1699-0463.1989.tb00746.x. [DOI] [PubMed] [Google Scholar]
  31. Fujinami R.S., Zurbriggen A., Powell H.C. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J. Neuroimmunol. 1988;20:25–32. doi: 10.1016/0165-5728(88)90110-5. [DOI] [PubMed] [Google Scholar]
  32. Fujinami R.S., Rosenthal A., Lampert P.W., Zurbriggen A., Yamada M. Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody. J. Virol. 1989;63:2081–2087. doi: 10.1128/jvi.63.5.2081-2087.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Graves M.C., Bologa L., Siegel L., Londe H. Theiler's virus in brain cell culture: Lysis of neurons and oligodendrocytes and persistence in astrocytes and macrophages. J. Neurosci. Res. 1986;15:491–501. doi: 10.1002/jnr.490150406. [DOI] [PubMed] [Google Scholar]
  34. Hogle J.M., Chow M., Filman D.J. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science. 1985;229:1358–1365. doi: 10.1126/science.2994218. [DOI] [PubMed] [Google Scholar]
  35. Hogle J.M., Chow M., Filman D.J. The structure of poliovirus. Sci. Am. 1987;255:42–49. doi: 10.1038/scientificamerican0387-42. [DOI] [PubMed] [Google Scholar]
  36. Kandolf R., Hofschneider P.H. Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus, full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1985;82:4818–4822. doi: 10.1073/pnas.82.14.4818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Kaplan G., Lubinski J., Dasgupta A., Racaniello V.R. In vitro synthesis of infectious poliovirus RNA. Proc. Natl. Acad. Sci. U.S.A. 1985;82:8424–8428. doi: 10.1073/pnas.82.24.8424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lang W., Wiley C., Lampert P. Theiler's virus encephalomyelitis is unaffected by treatment with myelin components. J. Neuroimmunol. 1985;9:109–113. doi: 10.1016/s0165-5728(85)80011-4. [DOI] [PubMed] [Google Scholar]
  39. Larsen G.R., Dorner A.J., Harris T.J.R., Wimmer E. The structure of poliovirus replicative form. Nucleic Acids Res. 1980;8:1217–1229. doi: 10.1093/nar/8.6.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lehrich J.R., Arnason B.G., Hochberg F.H. Demyelinating myelopathy in mice induced by the DA virus. J. Neurol. Sci. 1976;29:149–160. doi: 10.1016/0022-510x(76)90167-2. [DOI] [PubMed] [Google Scholar]
  41. Lindsley M.D., Rodriguez M. Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. J. Immunol. 1989;142:2677–2682. [PubMed] [Google Scholar]
  42. Lindsley M.D., Thiemann R.L., Rodriguez M. Expression of Class I antigen in C57/BL10 and SJL mice following Theiler's virus infection. J. Neuropathol. Exp. Neurol. 1988;47:324. [Google Scholar]
  43. Lipton H.L. Theiler's virus infection in mice, an unusual biphasic disease process leading to demyelination. Infect. Immun. 1975;11:1147–1155. doi: 10.1128/iai.11.5.1147-1155.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Lipton H.L. Characterization of the TO strains of Theiler's mouse encephalomyelitis viruses. Infect. Immun. 1978;20:869–872. doi: 10.1128/iai.20.3.869-872.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lipton H.L., Dal Canto M.C. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 1976;30:201–207. doi: 10.1016/0022-510x(76)90267-7. [DOI] [PubMed] [Google Scholar]
  46. Lipton H.L., Dal Canto M. Theiler's virus-induced demyelination, prevention by immunosuppression. Science. 1976;192:62–64. doi: 10.1126/science.176726. [DOI] [PubMed] [Google Scholar]
  47. Lipton H.L., Dal Canto M.C. Contrasting effects of immunosuppression on Theiler's virus infection in mice. Infect. Immun. 1977;15:903–909. doi: 10.1128/iai.15.3.903-909.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lipton H.L., Friedmann A. Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides, correlation of the polypeptide profile with virulence. J. Virol. 1980;33:1165–1172. doi: 10.1128/jvi.33.3.1165-1172.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Lipton H.L., Gonzalez-Scarano F. Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J. Infect. Dis. 1978;137:145–151. doi: 10.1093/infdis/137.2.145. [DOI] [PubMed] [Google Scholar]
  50. Lipton H.L., Melvold R. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 1984;132:1821–1825. [PubMed] [Google Scholar]
  51. Lipton H.L., Miller S., Melvold R., Fujinami R.S. Theiler's murine encephalomyelitis virus (TMEV) infection in mice as a model for multiple sclerosis. In: Notkins A.L., Oldstone M.B.A., editors. “Concepts in Viral Pathogenesis II”. Springer-Verlag; New York: 1986. pp. 248–254. [Google Scholar]
  52. Lloyd R.E., Grubman M.J., Ehrenfeld E. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. J. Virol. 1988;62:4216–4223. doi: 10.1128/jvi.62.11.4216-4223.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Lorch Y., Kotler M., Friedmann A. Persistent and acute central nervous system infections are caused by Theiler's murine encephalomyelitis viruses which differ in RNA composition but code for only slightly different proteins. J. Virol. 1984;52:960–965. doi: 10.1128/jvi.52.3.960-965.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Love S. Distribution of Theiler's virus in the CNS of athymic nude mice, effect of varying the route of inoculation. J. Neurol. Sci. 1987;81:55–66. doi: 10.1016/0022-510x(87)90183-3. [DOI] [PubMed] [Google Scholar]
  55. Luo M., Vriend G., Kamer G., Minor I., Arnold E., Rossmann M.G., Boege U., Scraba D.G., Duke G.M., Palmenberg A.C. The atomic structure of Mengo virus at 3.0 Å resolution. Science. 1987;235:182–191. doi: 10.1126/science.3026048. [DOI] [PubMed] [Google Scholar]
  56. Melnick J.L., Riordan J.T. Latent mouse encephalomyelitis. J. Immunol. 1947;57:331–342. [PubMed] [Google Scholar]
  57. Melvold R.W., Jokinen D.M., Knobler R.L., Lipton H.L. Variations in genetic control of susceptibility to Theiler's murine cencephalomyelitis virus (TMEV)-induced demyelinating disease. I. Differences between susceptible SJL/J and resistant BALB/C strains map near the T cell beta-chain constant genes on chromosome 6. J. Immunol. 1987;138:1429–1433. [PubMed] [Google Scholar]
  58. Miller S.D., Clatch R.J., Pevear D.C., Trotter J.L., Lipton H.L. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 1987;138:3776–3784. [PubMed] [Google Scholar]
  59. Mizutani S., Colonno R.J. In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14. J. Virol. 1985;56:628–632. doi: 10.1128/jvi.56.2.628-632.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Naviaux R.K., Cohen S.H., Vanden Brink K.M., Jordan G.W. Construction and characterization of two infectious clones of encephalomyocarditis virus. J. Virol. 1990;64:913–917. doi: 10.1128/jvi.64.2.913-917.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Nitayaphan S., Toth M.M., Roos R.P. Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J. Virol. 1985;53:651–657. doi: 10.1128/jvi.53.2.651-657.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Nitayaphan S., Toth M.M., Roos R.P. Localization of a neutralization site of Theiler's murine encephalomyelitis viruses. J. Virol. 1985;56:887–895. doi: 10.1128/jvi.56.3.887-895.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Nitayaphan S., Omilianowski D., Toth M.M., Parks G.D., Rueckert R.R., Palmenberg A.C., Roos R.P. Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology. 1986;26:140–148. doi: 10.1159/000149693. [DOI] [PubMed] [Google Scholar]
  64. Ohara Y., Roos R. The antibody response in Theiler's virus infection, new perspectives on multiple sclerosis. Prog. Med. Virol. 1987;34:156–179. [PubMed] [Google Scholar]
  65. Ohara Y., Stein S., Fu J., Stillman L., Klaman R., Roos P. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology. 1988;164:245–255. doi: 10.1016/0042-6822(88)90642-3. [DOI] [PubMed] [Google Scholar]
  66. Olitsky P.K. A transmissible agent (Theiler's virus) in the intestine of normal mice. J. Exp. Med. 1940;72:113–127. doi: 10.1084/jem.72.2.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Olitsky P.K. Certain properties of Theiler's virus, especially in relation to its use as model for poliomyelitis. Proc. Soc. Exp. Biol. Med. 1945;58:77–81. [Google Scholar]
  68. Olitsky P.K., Schlesinger R.W. Histopathology of CNS of mice infected with virus of Theiler's disease (spontaneous encephalomyelitis) Proc. Soc. Exp. Biol. Med. 1941;47:79–83. [Google Scholar]
  69. Omata T., Kohara M., Sakai Y., Kameda A., Imura N., Nomoto A. Cloned infectious complementary DNA of the poliovirus Sabin 1 genome, biochemical and biological properties of the recovered virus. Gene. 1984;32:1–10. doi: 10.1016/0378-1119(84)90026-x. [DOI] [PubMed] [Google Scholar]
  70. O'Neill R.E., Racaniello V.R. Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J. Virol. 1989;63:5069–5075. doi: 10.1128/jvi.63.12.5069-5075.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Ozden S., Tangy F., Chamorro M., Brahic M. Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus. J. Virol. 1986;60:1163–1165. doi: 10.1128/jvi.60.3.1163-1165.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Ozden S., Aubert C., Brahic M. Expression of Theiler's murine encephalomyelitis virus protease 3C and polymerase 3D in Escherichia coli and characterization of monospecific sera. Virology. 1988;165:560–596. doi: 10.1016/0042-6822(88)90604-6. [DOI] [PubMed] [Google Scholar]
  73. Page G.S., Mosser A.G., Hogle J.M., Filman D.J., Rueckert R.R., Chow M. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J. Virol. 1988;62:1781–1794. doi: 10.1128/jvi.62.5.1781-1794.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Parker R.C., Hollender A.J. Propagation of Theiler's GDVII mouse virus in tissue culture. Proc. Soc. Exp. Biol. Med. 1945;60:88–93. doi: 10.3181/00379727-60-15100. [DOI] [PubMed] [Google Scholar]
  75. Paya C.V., Patick A.K., Leibson P.J., Rodriguez M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 1989;143:95–102. [PubMed] [Google Scholar]
  76. Penney J.B., Wolinsky J.S. Neuronal and oligodendroglial infection by the WW strain of Theiler's virus. Lab. Invest. 1979;40:324–330. [PubMed] [Google Scholar]
  77. Pevear D.C., Calenoff M.A., Lipton H.L. Sequence comparison of a highly virulent and a less virulent (demyelinating) strain of Theiler's murine encephalomyelitis virus. J. Neuroimmunol. 1987;16:204. [Google Scholar]
  78. Pevear D.C., Calenoff M.A., Rozhon E., Lipton H.L. Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J. Virol. 1987;61:1507–1516. doi: 10.1128/jvi.61.5.1507-1516.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Pevear D.C., Borkowsky J., Calenoff M.A., Oh C.K., Ostrowski B., Lipton H.L. Insights into Theiler's virus neurovirulence based on a genomic comparison of the neurovirulent GDVII and less virulent BeAn strains. Virology. 1988;165:1–12. doi: 10.1016/0042-6822(88)90652-6. [DOI] [PubMed] [Google Scholar]
  80. Pevear D.C., Luo M., Lipton H.L. Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains, clustering of amino acid differences identifies possible locations of immunogenic sites on the virion. Proc. Natl. Acad. Sci. U.S.A. 1988;85:4496–4500. doi: 10.1073/pnas.85.12.4496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Powell H.C., Lehrich J.R., Arnason B.G. Electron-microscopic appearance of the DA virus, a demyelinating murine virus. J. Neurol. Sci. 1977;34:15–23. doi: 10.1016/0022-510X(77)90087-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Rabinowitz S.G., Lipton H.L. Cellular immunity in chronic Theiler's virus central nervous system infection. J. Immunol. 1976;117:357–363. [PubMed] [Google Scholar]
  83. Racaniello V.R., Baltimore D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science. 1981;214:916–919. doi: 10.1126/science.6272391. [DOI] [PubMed] [Google Scholar]
  84. Rauch H.C., Montgomery I.N. The role of the immune response in TMEV infection and the development of late onset demyelination. J. Immunol. 1988;136:2136–2140. [PubMed] [Google Scholar]
  85. Rauch H.C., Montgomery I.N., Hinman C.L., Harb W., Benjamins J.A. Chronic Theiler's virus infection in mice, appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP. J. Neuroimmunol. 1987;14:35–48. doi: 10.1016/0165-5728(87)90099-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Rodriguez M. Virus-induced demyelination in mice, “dying back” of oligodendrocytes. Mayo Clin. Proc. 1985;60:433–438. doi: 10.1016/s0025-6196(12)60865-9. [DOI] [PubMed] [Google Scholar]
  87. Rodriguez M., David C.S. Demyelination induced by Theiler's virus, influence of the H-2 haplotype. J. Immunol. 1985;135:2145–2148. [PubMed] [Google Scholar]
  88. Rodriguez M., Sriram S. Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. J. Immunol. 1988;140:2950–2955. [PubMed] [Google Scholar]
  89. Rodriguez M., Leibowitz J.L., Powell H.C., Lampert P.W. Neonatal infection with the Daniels strain of Theiler's murine encephalomyelitis virus. Lab. Invest. 1983;49:672–679. [PubMed] [Google Scholar]
  90. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 1983;13:426–433. doi: 10.1002/ana.410130409. [DOI] [PubMed] [Google Scholar]
  91. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 1986;163:620–631. doi: 10.1084/jem.163.3.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Rodriguez M., Lafuse W.P., Leibowitz J., David C.S. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products. Neurology. 1986;36:964–970. doi: 10.1212/wnl.36.7.964. [DOI] [PubMed] [Google Scholar]
  93. Rodriguez M., Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis, a model of demyelination and persistence of virus. CRC Crit. Rev. Immunol. 1987;7:325–365. [PubMed] [Google Scholar]
  94. Rodriguez M., Peirce M.L., Howie E.A. Immune response gene products (Ia antigen) on glial and endothelial cells in virus-induced demyelination. J. Immunol. 1987;138:3438–3442. [PubMed] [Google Scholar]
  95. Rodriguez M., Lucchinetti C.F., Clark R.J., Yaksh T.L., Markovitz H., Lennon V.A. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J. Immunol. 1988;140:800–806. [PubMed] [Google Scholar]
  96. Roos R.P., Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 1984;15:494–499. doi: 10.1002/ana.410150516. [DOI] [PubMed] [Google Scholar]
  97. Roos R.P., Firestone S., Wollmann R., Variakojis D., Arnason B.G.W. The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 1982;2:223–234. doi: 10.1016/0165-5728(82)90057-1. [DOI] [PubMed] [Google Scholar]
  98. Roos R.P., Nalefski E.A., Nitayaphan S., Variakojis R., Singh K.K. An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease. J. Neuroimmunol. 1987;13:305–314. doi: 10.1016/0165-5728(87)90066-x. [DOI] [PubMed] [Google Scholar]
  99. Roos R.P., Kong W.-P., Semler B.L. Polyprotein processing of Theiler's murine encephalomyelitis virus. J. Virol. 1989;63:5344–5353. doi: 10.1128/jvi.63.12.5344-5353.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Roos R.P., Stein S., Ohara Y., Fu J., Semler B.L. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 1989;63:5492–5496. doi: 10.1128/jvi.63.12.5492-5496.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Roos R.P., Stein S., Routbort M., Senkowski A., Bodwell T., Wollmann R. Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J. Virol. 1989;63:4469–4473. doi: 10.1128/jvi.63.10.4469-4473.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Rosenthal A., Fujinami R.S., Lampert P.W. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab. Invest. 1986;54:515–522. [PubMed] [Google Scholar]
  103. Rozhon E.J., Lipton H.L., Brown F. Characterization of Theiler's murine encephalomyelitis virus RNA. J. Gen. Virol. 1982;61:157–165. doi: 10.1099/0022-1317-61-2-157. [DOI] [PubMed] [Google Scholar]
  104. Rubio N., Cuesta A. Lack of cross-reaction between myelin basic proteins and putative demyelinating virus envelope proteins. Mol. Immunol. 1989;26:663–668. doi: 10.1016/0161-5890(89)90049-7. [DOI] [PubMed] [Google Scholar]
  105. Rueckert R.R. Picornaviridae and their replication. In: Fields B.N., Knipe D.M., Chanock R.M., Hirsch M.S., Melnick J.L., Monath T.P., Roizman B., editors. “Virology”. Raven; New York: 1990. pp. 507–548. [Google Scholar]
  106. Skern T., Sommergruber W., Blaas D., Gruendler P., Fraundorfer F., Pieler C.H., Fogy I., Kuechler E. Human rhinovirus 2, complete nucleotide sequence and proteolytic processing signals in the capsid protein region. Nucleic Acids Res. 1985;8:2111–2126. doi: 10.1093/nar/13.6.2111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Spriggs D.R., Fields B.N. Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (London) 1982;297:68–70. doi: 10.1038/297068a0. [DOI] [PubMed] [Google Scholar]
  108. Stroop W.G., Baringer J.R. Biochemistry of Theiler's murine encephalomyelitis virus isolated from acutely infected mouse brain: Identification of a previously unreported polypeptide. Infect. Immun. 1981;32:769–777. doi: 10.1128/iai.32.2.769-777.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Stroop W.G., Baringer J.R., Brahic M. Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab. Invest. 1981;45:504–509. [PubMed] [Google Scholar]
  110. Stroop W.G., Brahic M., Baringer J.R. Detection of tissue culture-adapted Theiler's virus RNA in spinal cord white matter cells throughout infection. Infect. Immun. 1982;37:763–770. doi: 10.1128/iai.37.2.763-770.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Takahara Y., Ando N., Kohara M., Hagiono-Yamagishi K., Nomoto A., Itho H., Numao N., Kondo K. Purification of enzymatically active poliovirus proteinase 3C produced in Escherichia coli. Gene. 1989;79:249–258. doi: 10.1016/0378-1119(89)90207-2. [DOI] [PubMed] [Google Scholar]
  112. Tangy F., McAllister A., Brahic M. Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J. Virol. 1989;63:1101–1106. doi: 10.1128/jvi.63.3.1101-1106.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Theiler M. Spontaneous encephalomyelitis of mice. A new virus disease. Science. 1934;80:122. doi: 10.1126/science.80.2066.122-a. [DOI] [PubMed] [Google Scholar]
  114. Theiler M. Spontaneous encephalomyelitis of mice. A new virus disease. J. Exp. Med. 1937;65:705–719. doi: 10.1084/jem.65.5.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Theiler M., Gard S. Encephalomyelitis of mice. I. Characterization and pathogenesis of the virus. J. Exp. Med. 1940;72:49–67. doi: 10.1084/jem.72.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Theiler M., Gard S. Encephalitis of mice. III. Epidemiology. J. Exp. Med. 1940;72:79–90. doi: 10.1084/jem.72.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. von Magnus H. Studies on mouse encephalomyelitis virus (TO strain). III. Spread and multiplication of TO virus in baby mice after various routes of inoculation. Acta Pathol. Microbiol. Scand. 1951;28:234–249. [PubMed] [Google Scholar]
  118. Welsh C.J., Tonks P., Nash A.A., Blakemore W.F. The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice. J. Gen. Virol. 1987;68:1659. doi: 10.1099/0022-1317-68-6-1659. [DOI] [PubMed] [Google Scholar]
  119. Wimmer E. The genome-linked protein of picornavirus: Discovery, properties, and possible functions. In: Perez-Bercoff R., editor. “The Molecular Biology of Picornaviruses”. Plenum; New York: 1979. pp. 175–190. [Google Scholar]
  120. Wroblewska Z., Gilden D.H., Wellish M., Rorke L.B., Warren K.G., Wolinsky J.S. Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab. Invest. 1977;37:595–602. [PubMed] [Google Scholar]
  121. Wroblewska Z., Kim S.U., Sheffield W.D., Gilden D.H. Growth of the WW strain of Theiler virus in mouse central nervous system organotypic culture. Acta Neuropathol. 1979;47:13–19. doi: 10.1007/BF00698267. [DOI] [PubMed] [Google Scholar]
  122. Yamada M., Zurbriggen A., Fujinami R.S. Monoclonal antibody to Theiler's virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 1990;171:1893–1907. doi: 10.1084/jem.171.6.1893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. M. Yamada A. Zurbriggen R.S. Fujinami (1990b). The relationship between viral RNA, myelin-specific mRNAs, and demyelination in the central nervous system disease during Theiler's virus infection. Am. J. Path. (in press). [PMC free article] [PubMed]
  124. Zibert A., Maass S., Strebel K., Falk M.M., Beck E. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 1990;64:2467–2473. doi: 10.1128/jvi.64.6.2467-2473.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Zurbriggen A., Fujinami R.S. Theiler's virus infection in nude mice: viral RNA in vascular endothelial cells. J. Virol. 1988;62:3589–3596. doi: 10.1128/jvi.62.10.3589-3596.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Zurbriggen A., Fujinami R.S. A neutralization-resistant Theiler's virus variant produces an altered disease pattern in the mouse central nervous system. J. Virol. 1989;63:1505–1513. doi: 10.1128/jvi.63.4.1505-1513.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Zurbriggen A., Hogle J.M., Fujinami R.S. Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J. Exp. Med. 1989;170:2037–2049. doi: 10.1084/jem.170.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Advances in Virus Research are provided here courtesy of Elsevier

RESOURCES